dna-istock-518143098-ralwel--2
ralwel / iStockphoto.com
10 April 2018Americas

Novartis signs $8.7bn gene therapy deal

Swiss drug maker Novartis is set to strengthen its gene therapy expertise with the $8.7 billion addition of Nasdaq-listed AveXis to its portfolio.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
27 March 2018   GSK has revealed that it will buy Novartis out of their joint consumer healthcare business.

More on this story

Big Pharma
27 March 2018   GSK has revealed that it will buy Novartis out of their joint consumer healthcare business.

More on this story

Big Pharma
27 March 2018   GSK has revealed that it will buy Novartis out of their joint consumer healthcare business.